Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients
- 31 July 2004
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 51 (1), 126-131
- https://doi.org/10.1016/j.jaad.2004.01.058
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Scleromyxedema revisitedInternational Journal of Dermatology, 2003
- Efficacy of a low dose of thalidomide in advanced multiple myelomaBlood, 2002
- Diffuse cutaneous mucinosesDermatologic Clinics, 2002
- Cutaneous MucinosesThe American Journal of Dermatopathology, 2001
- Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedemaJournal of the American Academy of Dermatology, 2001
- Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)Journal of the American Academy of Dermatology, 2000
- Scleromyxedema with dermato-neuro syndromeJournal of the American Academy of Dermatology, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaThe New England Journal of Medicine, 1999
- Fatal scleromyxedema: Report of a case and review of the literatureJournal of the American Academy of Dermatology, 1998
- ScleromyxedemaJournal of the American Academy of Dermatology, 1995